Validation of Laser Doppler Flowmetry to Identify Allergic Rhinitis Patients With Pharmacogenetic Alterations in Histamine Metabolism
NCT00362999 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 74
Last updated 2024-07-03
Summary
The hypothesis to be proven is that histamine iontophoresis with measurement of microvascular blood flow by laser Doppler flowmetry can be used as a reliable marker to characterize the normal microvascular cutaneous response to histamine.
Conditions
- Allergic Rhinitis
Sponsors & Collaborators
-
Children's Mercy Hospital Kansas City
lead OTHER
Principal Investigators
-
Bridgette L Jones, MD · Children's Mercy Hospital Kansas City
Eligibility
- Min Age
- 7 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-08-31
- Primary Completion
- 2024-07-31
- Completion
- 2024-07-31
Countries
- United States
Study Locations
More Related Trials
-
Mediators in Nasal Hyperreactivity in Allergic Rhinitis and Chronic Rhinosinusitis
NCT04286542 ·Status: UNKNOWN ·Phase: NA
-
Effect of Intranasal Anti-IgE Antibodies on IgE Production
NCT03019237 ·Status: COMPLETED ·Phase: NA
-
Integrative Omics Approach to Allergic Rhinitis
NCT03324100 ·Status: ACTIVE_NOT_RECRUITING
-
Influence of H1-antihistamines on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin.
NCT04399525 ·Status: COMPLETED ·Phase: NA
-
Systemic Mechanisms in Allergic Rhinitis: Assessment of Metabolomic Outcomes.
NCT02230475 ·Status: COMPLETED
-
Genetics of the Early and Late Response to Allergen Challenge
NCT01113697 ·Status: COMPLETED
-
Nasal Physiologic Reactivity of Nonallergic Rhinitics to Cold Air Provocation
NCT00415493 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Asthma and Rhinitis Symptoms Among Secondary School Students in Saudi Arabia
NCT01085916 ·Status: UNKNOWN
-
Nasal Allergen Challenge in Rhinitic Subjects
NCT01286129 ·Status: COMPLETED ·Phase: NA
-
Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges*
NCT01240889 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Nasal Inflammatory Biomarkers
NCT03450031 ·Status: COMPLETED ·Phase: NA
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MEMP1972A in Patients With Allergic Rhinitis
NCT01160861 ·Status: COMPLETED ·Phase: PHASE1
-
Montelukast in Seasonal Allergic Rhinitis - Fall 1999 Study (0476A-117)
NCT00963599 ·Status: COMPLETED ·Phase: PHASE3
-
Nasya in Allergic Rhinitis
NCT01503957 ·Status: COMPLETED ·Phase: PHASE3
-
Study of AHIST in Seasonal Allergic Rhinitis Patients
NCT01008397 ·Status: WITHDRAWN ·Phase: PHASE1
-
Brain-derived Neurotrophic Factor (BDNF) Single Nucleotide Gene Polymorphism and Nerve Growth Factor as Risk Factors That Increase Severity of Allergic Rhinitis
NCT05907733 ·Status: UNKNOWN
-
A Study of RO4989991 in Patients With Allergic Rhinitis
NCT01152619 ·Status: COMPLETED ·Phase: PHASE1
-
Study on the Effect and Mechanism of Aescine Sodium in the Treatment of Allergic Rhinitis
NCT06709079 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Theophylline in Rhinitis
NCT01132781 ·Status: COMPLETED ·Phase: PHASE2
-
Allergic Inflammation in Rhinitis Patients Following Nasal Allergen Challenge
NCT01657097 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis
NCT00561717 ·Status: COMPLETED ·Phase: PHASE4
-
Validation of a Combined Symptom and Medication Score in Patients Suffering From Allergic Rhinoconjunctivitis
NCT04071249 ·Status: COMPLETED
-
Monitoring Allergen Immunotherapy in Allergic Rhinitis
NCT05621356 ·Status: UNKNOWN
-
Perennial Allergic Rhinitis Study In Pediatric Subjects
NCT00108914 ·Status: COMPLETED ·Phase: PHASE3
-
Validation of an Allergic Rhinitis Control Test in Children
NCT03075917 ·Status: RECRUITING ·Phase: NA